These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18691764)

  • 21. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
    Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
    J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A search to predict potential for drug-induced cardiovascular toxicity.
    Hamlin RL
    Toxicol Pathol; 2006; 34(1):75-80. PubMed ID: 16507547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Torsade de pointes--a cause of Morgagni-Adam-Stokes attacks in patients with complete atrioventricular block].
    Antonelli D; Rozner E; Freedberg NA; Turgeman Y
    Harefuah; 2008 Mar; 147(3):204-6, 279. PubMed ID: 18488859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced torsades de pointes--a form of mechano-electric feedback?
    Fabritz L
    Cardiovasc Res; 2007 Nov; 76(2):202-3. PubMed ID: 17869232
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of sarcolemmal Ca(2+) entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure.
    Kijtawornrat A; Ziolo MT; Nishijima Y; Roche BM; Hamlin RL
    Int Heart J; 2010 Jul; 51(4):285-90. PubMed ID: 20716847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iatrogenic torsades de pointes].
    Hennemann A
    Med Monatsschr Pharm; 2001 Aug; 24(8):262-5. PubMed ID: 11515200
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular profile of the canine torsades de pointes arrhythmia model assessed by echocardiographic and haemodynamic methods.
    Takahara A; Sugiyama A; Satoh Y; Iwasaki H; Nakamura Y; Hashimoto K
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):35-40. PubMed ID: 17577314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome.
    Qi X; Yeh YH; Chartier D; Xiao L; Tsuji Y; Brundel BJ; Kodama I; Nattel S
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):295-304. PubMed ID: 19808480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
    Chang JH; Weng TI; Fang CC
    Am J Emerg Med; 2009 Oct; 27(8):1016.e1-3. PubMed ID: 19857426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a non-human primate model of drug-induced torsades de pointes.
    Beatch GN; Davis DR; Dickenson DR; Adaikan PG; Hayes E; Rhamberg M; Walker MJ
    Proc West Pharmacol Soc; 1997; 40():13-6. PubMed ID: 9436200
    [No Abstract]   [Full Text] [Related]  

  • 32. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the sedative agent, JM-1232(-) cause QT prolongation with subsequent torsades de pointes?
    Kato R; Watanabe R; Miki H; Ijiri Y; Hayashi T; Tanaka K
    Life Sci; 2009 Nov; 85(21-22):737-41. PubMed ID: 19833140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced torsades de pointes in patients aged 80 years or more.
    Paran Y; Mashav N; Henis O; Swartzon M; Arbel Y; Justo D
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):260-5. PubMed ID: 18676301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.
    Wang J; Tsukashita M; Nishina T; Marui A; Yoshikawa E; Muranaka H; Matsuoka S; Ikeda T
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):465-70. PubMed ID: 19185171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs and the QT interval--implications for dentistry.
    Wynn RL
    Gen Dent; 2005; 53(2):94-7. PubMed ID: 15833006
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced arrhythmia a difficult to catch adverse effect. New guidelines for increased cardiovascular safety].
    Darpö B
    Lakartidningen; 2006 Apr 5-11; 103(14):1094-5. PubMed ID: 16681092
    [No Abstract]   [Full Text] [Related]  

  • 39. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.
    Takahara A; Nakamura Y; Sugiyama A
    Eur J Pharmacol; 2008 Oct; 596(1-3):127-31. PubMed ID: 18786527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-QT syndrome and torsades de pointes in a patient with Takotsubo cardiomyopathy: an unusual case.
    Mahida S; Dalageorgou C; Behr ER
    Europace; 2009 Mar; 11(3):376-8. PubMed ID: 19095686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.